153 related articles for article (PubMed ID: 1384113)
1. Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution.
Szostecki C; Will H; Netter HJ; Guldner HH
Scand J Immunol; 1992 Oct; 36(4):555-64. PubMed ID: 1384113
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis.
Züchner D; Sternsdorf T; Szostecki C; Heathcote EJ; Cauch-Dudek K; Will H
Hepatology; 1997 Nov; 26(5):1123-30. PubMed ID: 9362351
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against "nuclear dots" in primary biliary cirrhosis.
Szostecki C; Guldner HH; Will H
Semin Liver Dis; 1997 Feb; 17(1):71-8. PubMed ID: 9089912
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis.
Szostecki C; Guldner HH; Netter HJ; Will H
J Immunol; 1990 Dec; 145(12):4338-47. PubMed ID: 2258622
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
6. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of anti-multiple nuclear dots/Sp100 autoantibodies.
Wichmann I; Montes-Cano MA; Respaldiza N; Alvarez A; Walter K; Franco E; Sanchez-Roman J; Núñez-Roldán A
Scand J Gastroenterol; 2003 Sep; 38(9):996-9. PubMed ID: 14531539
[TBL] [Abstract][Full Text] [Related]
8. Identification of major linear epitopes on the sp100 nuclear PBC autoantigen by the gene-fragment phage-display technology.
Blüthner M; Schäfer C; Schneider C; Bautz FA
Autoimmunity; 1999; 29(1):33-42. PubMed ID: 10052683
[TBL] [Abstract][Full Text] [Related]
9. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
[TBL] [Abstract][Full Text] [Related]
10. Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis.
Janka C; Selmi C; Gershwin ME; Will H; Sternsdorf T
Hepatology; 2005 Mar; 41(3):609-16. PubMed ID: 15726652
[TBL] [Abstract][Full Text] [Related]
11. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
[TBL] [Abstract][Full Text] [Related]
12. Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis.
Sternsdorf T; Guldner HH; Szostecki C; Grötzinger T; Will H
Scand J Immunol; 1995 Aug; 42(2):257-68. PubMed ID: 7631159
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.
Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL
Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422
[TBL] [Abstract][Full Text] [Related]
14. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders.
Muratori P; Muratori L; Cassani F; Terlizzi P; Lenzi M; Rodrigo L; Bianchi FB
Clin Exp Immunol; 2002 Jan; 127(1):172-5. PubMed ID: 11882049
[TBL] [Abstract][Full Text] [Related]
15. Detection of anti-SP100 antibodies in primary biliary cirrhosis. Comparison of ELISA and immunofluorescence.
Bauer A; Habior A; Kraszewska E
J Immunoassay Immunochem; 2013; 34(4):346-55. PubMed ID: 23859785
[TBL] [Abstract][Full Text] [Related]
16. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis.
Mytilinaiou MG; Meyer W; Scheper T; Rigopoulou EI; Probst C; Koutsoumpas AL; Abeles D; Burroughs AK; Komorowski L; Vergani D; Bogdanos DP
Clin Chim Acta; 2012 Aug; 413(15-16):1211-6. PubMed ID: 22503841
[TBL] [Abstract][Full Text] [Related]
18. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis.
Guldner HH; Szostecki C; Grötzinger T; Will H
J Immunol; 1992 Dec; 149(12):4067-73. PubMed ID: 1281200
[TBL] [Abstract][Full Text] [Related]
19. Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis.
Zurgil N; Bakimer R; Kaplan M; Youinou P; Shoenfeld Y
J Clin Immunol; 1991 Sep; 11(5):239-45. PubMed ID: 1795042
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay.
Villalta D; Sorrentino MC; Girolami E; Tampoia M; Alessio MG; Brusca I; Daves M; Porcelli B; Barberio G; Bizzaro N;
Clin Chim Acta; 2015 Jan; 438():135-8. PubMed ID: 25172039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
